| Dr John J Plosay Iii, MD | |
|
1700 E Walnut Ave, Suite 250, El Segundo, CA 90245-2605 | |
| (800) 882-9212 | |
| Not Available |
| Full Name | Dr John J Plosay Iii |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Sports Medicine |
| Location | 1700 E Walnut Ave, El Segundo, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871517953 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PS0010X | Emergency Medicine - Sports Medicine | MD428836 (Pennsylvania) | Primary |
| Entity Name | Victory Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932402716 PECOS PAC ID: 9133301732 Enrollment ID: O20110302000980 |
News Archive
Connecting a human gene to the risk of developing the Alzheimer's precondition known as Mild Cognitive Impairment has been somewhat of a holy grail for scientists, but a team led by researchers from Cornell University has ended the quest.
Researchers with the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center and UAB Department of Chemistry have won an $805,000 grant from the U.S. Department of Defense Breast Cancer Research Program to study whether dead cancer cells left over after treatment encourage cancer's spread to other parts of the body.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.
When treatment guidelines for a particular disease emerge, they are often published in a peer-reviewed medical journal, which can take up to three years. One University of Alabama at Birmingham infectious diseases expert recently helped develop new Hepatitis C virus (HCV) guidelines that can be updated and published as new data emerge and new therapies are approved.
Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove very small breast cancers that can be seen on a mammogram but not felt in the breast.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John J Plosay Iii, MD 1322 Annandale Ter, Pasadena, CA 91105-2262 Ph: (626) 403-0071 | Dr John J Plosay Iii, MD 1700 E Walnut Ave, Suite 250, El Segundo, CA 90245-2605 Ph: (800) 882-9212 |
News Archive
Connecting a human gene to the risk of developing the Alzheimer's precondition known as Mild Cognitive Impairment has been somewhat of a holy grail for scientists, but a team led by researchers from Cornell University has ended the quest.
Researchers with the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center and UAB Department of Chemistry have won an $805,000 grant from the U.S. Department of Defense Breast Cancer Research Program to study whether dead cancer cells left over after treatment encourage cancer's spread to other parts of the body.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.
When treatment guidelines for a particular disease emerge, they are often published in a peer-reviewed medical journal, which can take up to three years. One University of Alabama at Birmingham infectious diseases expert recently helped develop new Hepatitis C virus (HCV) guidelines that can be updated and published as new data emerge and new therapies are approved.
Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove very small breast cancers that can be seen on a mammogram but not felt in the breast.
› Verified 7 days ago
Monica E. Breedlove, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 390 N Pacific Coast Hwy Ste 3000, El Segundo, CA 90245 Phone: 818-287-7409 | |
Dr. Christopher Lee Hammond, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 898 N Pacific Coast Hwy Ste 600, El Segundo, CA 90245 Phone: 310-279-2134 | |
Alexander Judson Moore Ruby, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 898 N Pacific Coast Hwy Ste 600, El Segundo, CA 90245 Phone: 310-379-2134 | |
Dr. Sobiya Khan, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 390 N Pacific Coast Hwy Ste 3000, El Segundo, CA 90245 Phone: 917-656-9767 | |
Dr. Sara Levy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1700 E Walnut Ave Ste 250, El Segundo, CA 90245 Phone: 213-748-2411 | |
Dale P Curtis, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2101 Rosecrans Ave Ste 3230, El Segundo, CA 90245 Phone: 323-628-8671 |